Renal Impairment Clinical Trials

256 clinical trials for Renal Impairment across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006) — RECRUITING · PHASE1
• A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function — RECRUITING · PHASE1
• Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function — RECRUITING · PHASE1
• A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease — RECRUITING · PHASE1
• A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function — RECRUITING · PHASE1
• Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes — RECRUITING · NA
• Pharmacokinetics and Safety of Rupatadine in Participants With Renal Impairment Compared to Control Participants — RECRUITING · PHASE1
• Development of a Biomarker Panel for the Earlier Prediction of Acute Kidney Injury in Patients With Diabetes — RECRUITING
• Renal Impairment Pharmacokinetics (PK) Trial of Afabicin — NOT_YET_RECRUITING · PHASE1
• A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in People With Normal or Decreased Kidney Functions — NOT_YET_RECRUITING · PHASE1
• Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function — COMPLETED · PHASE1
• Study to assess the plasma concentration of rilzabrutinib given as a tablet to adult participants with severe renal impairment compared to matched participants with normal renal function — NOT_YET_RECRUITING · PHASE1
• The Study is to Investigate D-2570 in Participants With Different Levels of Kidney Function. — NOT_YET_RECRUITING · PHASE1
• Single-Dose Study to Evaluate the PKs of Pretomanid in Participants With Renal Impairment Compared to Participants With Normal Renal Function — COMPLETED · PHASE1
• Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment — COMPLETED · PHASE1
• A Study of S-892216-PO in Participants With Renal Impairment and Matched Controls — COMPLETED · PHASE1
• Pharmacokinetics and Safety Study of YZJ-1139 in Subjects With Severe Renal Impairment and Normal Renal Impairment — COMPLETED · PHASE1
• Pharmacokinetics and Safety Study of Levornidazole Disodium Phosphate for Injection in Subjects With Renal Impairment and Normal Renal Impairment — COMPLETED · PHASE1
• Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373) — COMPLETED · PHASE1
• Effect of Renal Impairment on Enpatoran Pharmacokinetics — COMPLETED · PHASE1
• A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment — COMPLETED · PHASE1
• A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants With Severe Renal Impairment, End-stage Kidney Disease, and in Healthy Participants — COMPLETED · PHASE1
• Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy — ACTIVE_NOT_RECRUITING · NA
• A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems — COMPLETED · PHASE1
• Ultra-low Dose Contrast for Endovascular Procedures — COMPLETED
• Study of BPN14770 in Participants With Severe Renal Impairment and Healthy Controls — COMPLETED · PHASE1
• A Study of MK-8527 in Participants With Moderate and Severe Renal Impairment (MK-8527-008) — COMPLETED · PHASE1
• A Clinical Study of Calderasib (MK-1084) in Participants With Renal Impairment (MK-1084-010) — COMPLETED · PHASE1
• Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function — COMPLETED · PHASE1
• An Investigational Study of ESK-001 in Participants With Normal Renal Function and Participants With Mild, Moderate, and Severe Impaired Renal Function — COMPLETED · PHASE1
• Assessment of Renal Function by Multiparametric MRI — COMPLETED · PHASE1
• Incidence of HANA Conditions in HIV-infected Individuals — COMPLETED
• A Study to Investigate the Pharmacokinetics, Safety and Tolerability of AZD5462 in Participants With Renal Impairment — COMPLETED · PHASE1
• A Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Olpasiran in Participants With Normal Renal Function and Participants With Various Degrees of Renal Impairment — COMPLETED · PHASE1
• Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD6234 — COMPLETED · PHASE1
• Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function — COMPLETED · PHASE1
• A Study to Evaluate BMS-986278 in Participants With Normal Renal Function, Severe Renal Impairment, or End-Stage Renal Disease on Intermittent Hemodialysis — COMPLETED · PHASE1
• A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses (6 Days) of 100 mg Resmetirom in Subjects With Severe Renal Impairment and in Matched Healthy Control Subjects With Normal Renal Function — COMPLETED · PHASE1
• AZD3427 Effects on Renal Perfusion in Heart Failure Patients With Reduced Ejection Fraction and Renal Impairment — TERMINATED · PHASE1
• A Phase Ib Study of AZD5462 on Top of Dapagliflozin in Participants With Heart Failure and Moderate Renal Impairment — TERMINATED · PHASE1
• The Effect of Severe Kidney Impairment on Cenerimod Pharmacokinetics — COMPLETED · PHASE1
• DESIR. Evaluation of the Pre-therapeutic Activity of Dihydropyrimidine dEShydrogenase (DPD) in Patients With Cancer and/or Renal Failure — NOT_YET_RECRUITING
• Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment — TERMINATED · PHASE4
• Assessment of the Pharmacokinetics and Safety of ANT3310 Combined With Meropenem in Renally Impaired Subjects — COMPLETED · PHASE1
• A Clinical Study of Enlicitide in Participants With Severe Renal Impairment (MK-0616-032) — COMPLETED · PHASE1
• Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose — COMPLETED · PHASE1
• A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics and Safety of VIR-2218 — COMPLETED · PHASE1
• A Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD5004 — COMPLETED · PHASE1
• A Study to Evaluate the Drug Levels of Mezigdomide in Adult Participants With Renal Impairment — COMPLETED · PHASE1
• A Phase 1, Open-Label, Non-Randomized, Single-Center, Single-Dose Study to Assess the Pharmacokinetics and Safety of ANT3310 Combined with Meropenem Administered as a Single Intravenous Infusion to Adult Subjects with Renal Function Impairment — OTHER · PHASE1

Refine this search